Skip to main content
Industry News
Researchers say skin cancer vaccine effective for 4 years

A skin cancer vaccine developed by researchers at the Dana-Farber Cancer Institute was effective for up to four years, according to a study reported in the journal Nature. The eight patients involved in the study received the NeoVax vaccine about 18 weeks after having tumors removed.

Full Story: